You can read Jo Churchill's latest speeches and appearances in Parliament below:
The Secretary of State for Health and Social Care has discussed access to Spinraza with NHS England and NHS Improvement. My Rt hon.
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period.
The Department, in consultation with the devolved administrations and Crown Dependencies, is working with trade bodies, product suppliers
We are informed by the National Institute for Health and Care Excellence (NICE) that its methods review is proceeding apace, and NICE is
Departmental Ministers and officials regularly discuss a range of matters with colleagues in the National Institute for Health and Care E
The patient registry for cannabis-based products for medicinal use is currently being developed by NHS England and NHS Improvement with i
Enzyme replacement therapy for CLN2 (Batten disease) is available through a managed access agreement.
The Department relies on competition to keep the prices of unbranded generic medicines down.